SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-021094
Filing Date
2024-02-27
Accepted
2024-02-27 16:05:38
Documents
71
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kura-20231231.htm   iXBRL 10-K 2816756
2 EX-23.1 kura-ex23_1.htm EX-23.1 5807
3 EX-31.1 kura-ex31_1.htm EX-31.1 14527
4 EX-32.1 kura-ex32_1.htm EX-32.1 8219
5 EX-97.1 kura-ex97_1.htm EX-97.1 61865
6 GRAPHIC img338930_0.jpg GRAPHIC 181302
7 GRAPHIC img338930_1.jpg GRAPHIC 336040
  Complete submission text file 0000950170-24-021094.txt   11362720

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kura-20231231.xsd EX-101.SCH 1462644
73 EXTRACTED XBRL INSTANCE DOCUMENT kura-20231231_htm.xml XML 1631392
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37620 | Film No.: 24686495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)